Evolution, Not Revolution, Marks Progress In Targeted Oncology Therapy – AACR
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
The American Association for Cancer Research’s second annual Cancer Progress Report makes the case that oncology progression is more a process of refinement than breakthrough right now.